Trospium Chloride Extended-Release Capsules, 60 mg, 30 Capsules per bottle, Rx Only, Manufactured By: Sidmak Laboratories (India) Pvt. Ltd. Plot No. 20, Pharmacity, Selaqui Industrial Area, Dehradun-248 197 Uttarakhand, India Distributed By: Padagis, Allegan, MI 49010. NDC: 0574-0118-30
Published December 13, 2023 · Recall initiated: November 1, 2023
Summary
FDA records drug Class II recall D-0139-2024, published December 13, 2023 and initiated November 1, 2023. Recalling firm: Padagis US LLC; Status: Ongoing; Reported quantity: 7,032 bottles; Lot: Lot: 231104, 231105, 231106, exp 7/31/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Tablets/Capsules specifications; missing/broken/extra tablets within the capsules
What to do
Voluntary: Firm initiated · Letter
Get an email if TROSPIUM CHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- TROSPIUM CHLORIDE
- Manufacturer
- Padagis US LLC
- Distributor
- Nationwide in the USA
- Lot
- Lot: 231104, 231105, 231106, exp 7/31/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADr. Ergin's SugarMD, ADVANCED GLUCOSE SUPPORT Capsules, Dietary Supplement, helps support healthy glucoseDecember 13, 2023
- FDALET Gel (Lidocaine HCL/Epinephrine Bitartrate/Tetracaine HCL 4%/0.18%/0.5% Topical Gel), Single-use TopicalDecember 13, 2023
- FDAbuPROPion Hydrochloride Extended-Release Tablets, USP (SR) 200 mg, 60 Tablets bottle, Distributed by: SunDecember 13, 2023
- FDAceFAZolin sodium in Sterile Water for injection, Injectable Solution, 1g/10mL (0.1 g per mL), Syringe, RxDecember 13, 2023
- FDAKinderMed KIDS' PAIN & FEVER Acetaminophen, 160 mg per 5 mL bottles, Oral Suspension, Organic Cherry Flavor, 4December 13, 2023
- FDAICM LNQ22 LINQ II, Model LNQ22; Insertable Cardiac MonitorDecember 6, 2023
Questions about this recall
Was Trospium Chloride Extended-Release Capsules, 60 mg, 30 Capsules per bottle, Rx Only, Manufactured By: Sidmak Laboratories (India) Pvt. Ltd. Plot No. 20, Pharmacity, Selaqui Industrial Area, Dehradun-248 197 Uttarakhand, India Distributed By: Padagis, Allegan, MI 49010. NDC: 0574-0118-30 recalled?
Yes. FDA published recall D-0139-2024 on December 13, 2023. Reported hazard: Failed Tablets/Capsules specifications; missing/broken/extra tablets within the capsules
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: TROSPIUM CHLORIDE.